Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasmActive, not recruitingPhase 32026-05-15NCT04927780

3 results · Page 1 of 1

Swipe the table sideways for more columns.

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Amphia HospitalBredaNetherlands11
Amsterdam UMCAmsterdamNetherlands85
Catharina HospitalEindhovenNetherlands20
Deventer HospitalDeventerNetherlands6
Erasmus MC University Medical CenterRotterdamNetherlands2
Isala hospitalZwolleNetherlands5
Jeroen Bosch Hospital's-HertogenboschNetherlands9
Karolinska University HospitalStockholmSweden87
Leiden University Medical CenterLeidenNetherlands54
Maasstad ZiekenhuisRotterdamNetherlands20
Maastricht UMC+MaastrichtNetherlands22
Meander Medical CenterAmersfoortNetherlands3
Medical Center LeeuwardenLeeuwardenNetherlands5
Medisch Spectrum TwenteEnschedeNetherlands36
OLVGAmsterdamNetherlands21
Radboud University Medical CenterNijmegenNetherlands40
Regional Academic Center Utrecht, Antonius HospitalUtrechtNetherlands1
Sahlgrenska University HospitalGothenburgSweden96
Skåne University HospitalLundSweden39
Tjongerschans HospitalHeerenveenNetherlands1
University Medical Center GroningenGroningenNetherlands66